共 50 条
- [2] RACIAL DISPARITIES IN FUTURE DEVELOPMENT OF LETHAL PROSTATE CANCER BASED ON PSA LEVELS IN MIDLIFE [J]. JOURNAL OF UROLOGY, 2023, 209 : E1102 - E1103
- [5] BASELINE PSA LEVELS IN MIDLIFE & FUTURE DEVELOPMENT OF LETHAL PROSTATE CANCER: A DIVERSE NORTH AMERICAN COHORT ANALYSIS [J]. JOURNAL OF UROLOGY, 2023, 209 : E545 - E545
- [6] PSA levels within 2 years of diagnosis do not predict lethal prostate cancer outcomes [J]. Nature Clinical Practice Urology, 2007, 4 (7): : 351 - 352
- [8] BASELINE PROSTATE-SPECIFIC ANTIGEN (PSA) LEVELS IN MIDLIFE PREDICT TOTAL AND AGGRESSIVE PROSTATE CANCER IN AFRICAN-AMERICAN MEN [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E546 - E546
- [10] MIDLIFE BASELINE PSA AS A PREDICTOR OF LETHAL PROSTATE CANCER: RACIAL DIFFERENCES BETWEEN BLACK AND WHITE MEN [J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E310 - E310